Johnson & Johnson stock at EUR 250.30, up 2.10% premarket
Published on 11/09/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for Monday trading
- The premarket indication points to a stronger start than Friday's Xetra close.
- Johnson & Johnson operates across medicines, medical devices and consumer health.
Johnson & Johnson stock traded at 250.30 euros on Lang & Schwarz at 07:50 CET on Monday, November 9, 2026, 2.10 percent above the Xetra close of Friday, November 6.
Healthcare portfolio remains in focus
Johnson & Johnson operates across medicines, medical devices and consumer health. That broad portfolio gives investors several business areas to monitor as the new trading week begins.
The premarket move places the indication clearly above the last completed Xetra session. Investors will focus on whether the European listing maintains that strength once regular trading begins, without treating the early indication as a forecast for the closing price.
Investors can follow the real-time quote of Johnson & Johnson stock during the session.
The broader S&P 500 market environment remains the relevant index backdrop for the US-listed healthcare group.
More news and analyses on Johnson & Johnson stock provide further context for the company and its pipeline.
